Interact to see
Advertisement
Advertisement
MEDBX vs REBAX
MEDBX vs REBAX Comparison
Open Charts MEDBX vs REBAX
MFS Emerging Markets Debt B
Price$12.23
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets7.24B
Columbia Emerging Markets Bond A
Price$9.65
Change-$0.01 (-0.10%)
VolumeN/A
Net Assets287.65M
MEDBX vs REBAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VS
MEDBX vs. REBAX commentary
Jun 30, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MEDBX is a Hold and REBAX is a Hold.
FUNDAMENTALS
Fundamentals
MEDBX has more cash in the bank: 7.24B vs. REBAX (288M). MEDBX pays higher dividends than REBAX: MEDBX (5.69) vs REBAX (5.12). MEDBX was incepted earlier than REBAX: MEDBX (23 years) vs REBAX (19 years). MEDBX (1.82) is less costly to investors than REBAX (1.13). MEDBX is a more actively managed with annual turnover of: 58.00 vs. REBAX (41.00). MEDBX has a lower initial minimum investment than REBAX: MEDBX (1000) vs REBAX (2000). REBAX (8.48) and MEDBX (8.18) have marching annual gain over last year. REBAX return over 5 years is better than : 10.15 vs. MEDBX (7.26).
| MEDBX | REBAX | MEDBX / REBAX | |
| Total Expense Ratio | 1.81 | 1.13 | 160% |
| Annual Report Gross Expense Ratio | 1.82 | 1.13 | 161% |
| Fund Existence | 23 years | 19 years | - |
| Gain YTD | 3.981 | 4.639 | 86% |
| Front Load | N/A | 5% | - |
| Min. Initial Investment | 1000 | 2000 | 50% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 7.24B | 288M | 2,514% |
| Annual Yield % from dividends | 5.69 | 5.12 | 111% |
| Returns for 1 year | 8.18 | 8.48 | 96% |
| Returns for 3 years | 25.19 | 26.33 | 96% |
| Returns for 5 years | 7.26 | 10.15 | 72% |
| Returns for 10 years | 27.22 | 34.30 | 79% |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement